Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Globe Textiles will add a garment processing capacity of up to 20,000 units per day and 6 Lakh units per month Business
  • Triplanza Private Limited start-up invested 1 lakh and makes 1 lakh sales every month Lifestyle
  • Biotechnology appears sustainable solution to achieve self-sufficiency in oilseeds and pulses Business
  • Blum and Renowned Architects Unveil a Fusion of Artistry at ACETECH Mumbai 2023: A World of Innovation and Elegance Business
  • MAG Finserv enters into a Co-Lending Partnership for Gold Loans with Central Bank of India Business
  • Adnaan Shaikh, curator, entertainer, social media influencer and now an Entrepreneur, crosses the 10M mark on Insta Lifestyle
  • Tempt India forges partnership with Staunch Electronics to manufacture power banks in India, Furthering make-in-India initiative Business
  • Free NEET and JEE Crash Course for the Underprivileged Students Press Release

Remlife Global Partners With JiyaYu Lifesciences To Replace Animal Inputs In APIs Via Green Chemistry

Posted on May 9, 2025 By

New Delhi [India], May 9: Remlife Global PTE LTD., a Singapore-based subsidiary of BSE-listed Remedium Lifecare Ltd. (India), is pleased to announce a forward-looking partnership with JiyaYu Lifesciences PTE Ltd., a green chemistry technology platform company. This collaboration is focused on replacing animal-origin raw materials in the manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates through proprietary fermentation and biocatalyst-based alternatives.

As part of the partnership, JiyaYu will license out fully developed and scalable technologies to Remlife Global on an exclusive basis. These technologies are designed to replace traditional animal-derived steps with sustainable, cost-effective, and regulatorycompliant bioprocesses. Remlife Global will scale up and commercialise these technologies at one or more GMP-compliant contract manufacturing sites across India, Singapore, Malta, Ireland, Belgium, and Italy.

JiyaYu Lifesciences has in turn partnered with a UK-based R&D technology platform specialising in the development of fermentation and biocatalystbased alternatives to animal-origin pharmaceutical inputs. Through this collaboration, JiyaYu gains access to cutting-edge innovations that it will transfer to Remlife Global as fully scalable technologies.

Each technology will be supported by detailed process dossiers and full technology transfer documents, enabling Remlife Global to implement, validate, and scale up the processes at approved GMP manufacturing sites.

These solutions will support Remlife Global’s vision of eliminating dependence on vulnerable and ethically complex supply chains, while capturing new commercial opportunities in global regulated markets.

“Our collaboration with JiyaYu Lifesciences is a transformative move toward building a more ethical, resilient, and sustainable pharmaceutical supply chain.” said Adarsh Munjal.

Financial Outlook

Each technology platform has a minimum commercial potential of ₹50 crore per product, with EBITDA margins estimated between 20% to 25%. Assuming a scale-up of two products per year, cumulative revenue and EBITDA could grow substantially:

  • FY26: 2 products | ₹100 Cr revenue | ₹20–25 Cr EBITDA
  • FY27: 4 products | ₹200 Cr revenue | ₹40–50 Cr EBITDA

Moving Beyond Animal-Based Inputs

Remlife Global’s strategic direction is anchored in the belief that the future of pharmaceuticals lies in sustainable, animal-free production. Key reasons for this shift include:

  • Ethical and ESG Alignment: Modern pharmaceutical companies are under growing pressure to remove animal-based components from their supply chains.
  • Safety & Quality Control: Fermentation and biocatalyst-based systems offer superior consistency and eliminate the risk of contamination from animal-borne pathogens.
  • Supply Chain Resilience: Diseases, regulatory shifts, and geopolitical volatility all threaten the availability of animal-derived inputs.
  • Environmental Benefits: Traditional animal-derived raw materials are linked to high emissions, land use, and water consumption.
  • Industry Momentum: Leading global pharma firms are rapidly adopting bio-based and cruelty-free technologies in their development pipelines.

About Remlife Global PTE LTD.

Remlife Global PTE LTD. is the international innovation arm of Remedium Lifecare Ltd. (India), a BSE-listed pharmaceutical company. With a focus on R&D commercialisation and strategic collaborations, Remlife Global is driving the transition to sustainable API Contract manufacturing across multiple global jurisdictions.

Media Contact

Adarsh Munjal

Remlife Global PTE LTD.

Email: info@remlife.sg

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: Troika Tech Launches AI Election Marketing for State and Local Polls in India
Next Post: A life stage at a time: How two underserved districts in Karnataka are redefining disability support

Related Posts

  • KalonGens, Start-up by Former Boxer Keshav, provides Unbeatable Talent-Powered Solutions For Advance Business Success Business
  • Arindam Chaudhuri of IIPM explains why “Big corporations want knowledge not degrees” Business
  • Raveena Tandon to endorse the brand Garden’s Need, a Leading Manufacturer of planters Business
  • Temple Connect launches The Indian Puja Box Business
  • Top 10 Facebook Ads Agencies – (Latest 2025) Business
  • edForce launches “ElevateEdge” to create Soft Skill Excellence in the Indian IT Industry Business

Recent Posts

  • ‘Waste To Wealth’ , Unveiling the Untapped Potential of Waste Management
  • Stray Dog Menace: Government of India Pushes Humane ABC Rules with Funds, Community Role
  • Apna Vikas: A.I.-Based Mentor & Coach To Manage People And Their Perspectives
  • Paryushan 2025: Why India’s Most Introspective Festival Is Gaining Global Relevance
  • Unified Mentor to Launch “KYC – Know Your CTC” on 25th August: India’s First AI-Based Career Readiness Platform

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • SpEd@home Receives Seed Funding from Science and Technology Park, Pune (Sci Tech Park) through the Start-Up India Seed Fund Scheme Business
  • Indxx Licenses Artificial Intelligence and Big Data Index to Global X Canada for an ETF Technology
  • Muldooneys Paris launches French luxury handbags inspired by Warrior Goddess Meenakshi; Now Powered by NFT Technology Lifestyle
  • Oktoberfest: India Will Witness For The First Time! Lifestyle
  • Launch of Imarticus Learning in Jammu & Kashmir (UT) Imarticus Learning Inaugural Career Expo Press Release
  • Primex Media Services Pvt Ltd launches the e-magazine ‘Hello Entrepreneurs’ Business
  • Industry gearing up for Asia’s largest show on woodworking, furniture manufacturing & mattress manufacturing – DELHIWOOD 2023 Business
  • Ajeet Joshi, the youth and most popular celebrity Astrologer Business

Copyright © 2025 Daily News India.

Powered by PressBook News WordPress theme